Study China Desk

中国大学QS排名2025

中国大学QS排名2025:生命科学与医学学科排名

The 2025 QS World University Rankings by Subject place 12 Chinese mainland universities in the top 100 for **Life Sciences & Medicine**, up from 8 in 2023. P…

The 2025 QS World University Rankings by Subject place 12 Chinese mainland universities in the top 100 for Life Sciences & Medicine, up from 8 in 2023. Peking University leads at 22nd globally, followed by Tsinghua University at 25th, while Fudan University and Shanghai Jiao Tong University both entered the top 50 for the first time. The ranking, released by Quacquarelli Symonds (QS) in April 2025, evaluated 1,500+ institutions across five broad subject areas, using metrics including academic reputation (40%), employer reputation (10%), research citations per paper (20%), H-index (20%), and international research network (10%). China’s Ministry of Education reported that 492,185 international students studied in China in 2024, with 18.3% enrolled in health-related programs — the second-largest field after engineering. For prospective students weighing study abroad destinations, the data signals a clear trajectory: Chinese medical schools are closing the gap with traditional Western leaders, offering competitive research output at a fraction of the tuition cost.

Why QS Subject Rankings Matter for Medical Applicants

QS subject rankings differ from overall university rankings by focusing on discipline-specific performance. For a student targeting a career in medicine, biomedical engineering, or pharmaceutical sciences, a university’s global rank in Life Sciences & Medicine carries more weight than its composite score. The 2025 methodology weights academic peer review at 40%, meaning the reputation of Chinese medical faculties among global scholars has risen sharply. Tsinghua’s School of Medicine, for example, saw its academic reputation score jump 14 points since 2022, according to QS data. Employer reputation — 10% of the score — reflects how graduates perform in hospitals and research institutes worldwide. Chinese universities now hold 6 of the top 20 spots in the employer reputation sub-score for Life Sciences, a metric that directly impacts job placement for international graduates returning home or staying in China.

H3: The 40% Academic Reputation Factor

Academic reputation surveys are sent to 130,000+ scholars globally. In 2025, Chinese institutions received 23% more nominations in Life Sciences than in 2023, indicating growing recognition.

H3: Citation Impact and H-Index

China’s average citations per paper in life sciences rose to 18.4 in 2025, up from 15.2 in 2022 (Scimago Journal Rank). The H-index — measuring productivity and citation impact — for top Chinese medical schools now exceeds 120, comparable to the University of Melbourne and Johns Hopkins.

Top 10 Chinese Universities in Life Sciences & Medicine 2025

The following table lists the 10 highest-ranked Chinese mainland universities in QS Life Sciences & Medicine 2025, with their global rank and year-over-year change:

University2025 Global RankChange from 2024
Peking University22+3
Tsinghua University25+2
Fudan University44+6
Shanghai Jiao Tong University48+5
Zhejiang University56+4
Sun Yat-sen University63+7
Huazhong University of Science and Technology72+9
Wuhan University78+11
Nanjing University85+3
Sichuan University91+8

Peking University Health Science Center (PUHSC) remains the flagship, with 8 affiliated hospitals and 12,000+ beds. Its international student body includes 1,200+ degree-seeking students from 78 countries. The university’s research expenditure in life sciences reached ¥3.2 billion (USD $440 million) in 2024, according to its annual report.

How to Apply: CSC Scholarships and Self-Funded Pathways

International students can apply to Chinese medical programs through two main routes: the Chinese Government Scholarship (CSC) or self-funded enrollment. CSC scholarships cover tuition, accommodation, monthly stipends (¥3,000–¥5,000/USD $415–$690), and comprehensive medical insurance. In 2024, the China Scholarship Council awarded 6,800 scholarships for health sciences, with a 12.4% acceptance rate for life sciences applicants. Self-funded students pay tuition ranging from ¥30,000–¥80,000 per year (USD $4,150–$11,060), depending on the university and program — significantly lower than US or UK equivalents. For cross-border tuition payments, some international families use channels like Flywire tuition payment to settle fees in local currency with guaranteed exchange rates.

H3: Application Timeline

CSC applications open in January and close in April for September intake. Self-funded deadlines vary by university, typically between March and June. Documents required include transcripts, recommendation letters, a study plan, and HSK 4 or above for Chinese-taught programs. English-taught MBBS programs require IELTS 6.0 or TOEFL 80.

Program Types: MBBS, BDS, and Research Degrees

Chinese universities offer three primary program types in life sciences and medicine. The MBBS (Bachelor of Medicine, Bachelor of Surgery) is a 6-year program taught in English at 45+ universities, recognized by the World Health Organization (WHO) and the Educational Commission for Foreign Medical Graduates (ECFMG). In 2025, China graduated 8,200 international MBBS students, according to the Ministry of Education. BDS (Bachelor of Dental Surgery) programs run 5 years, offered at 22 universities. For graduate students, MSc and PhD in Life Sciences typically last 2–3 years and 3–4 years respectively, with research foci in oncology, neuroscience, genetics, and pharmacology.

H3: Clinical vs. Research Tracks

Clinical programs (MBBS/BDS) require hospital rotations in affiliated hospitals — Peking University’s PUHSC rotates students through 8 hospitals with 50,000+ annual inpatients. Research tracks (MSc/PhD) focus on lab work, with access to national key laboratories like the State Key Laboratory of Natural and Biomimetic Drugs.

Regional Hubs: Beijing, Shanghai, and Guangzhou

Three cities dominate China’s life sciences education landscape. Beijing hosts Peking University and Tsinghua University, plus 34 national-level research institutes. The city’s Zhongguancun Life Science Park houses 600+ biotech companies, providing internship and employment opportunities. Shanghai — home to Fudan and Shanghai Jiao Tong — has the Zhangjiang Pharmaceutical Valley, China’s largest biomedical cluster, with 1,200+ enterprises generating ¥280 billion in revenue in 2024. Guangzhou features Sun Yat-sen University and its 10 affiliated hospitals, serving a population of 18 million in the Greater Bay Area. International students in Guangzhou benefit from lower living costs (¥2,500–¥4,000/month vs. ¥4,000–¥6,000 in Beijing) and year-round subtropical climate.

H3: Cost of Living Comparison

Monthly living expenses for international students: Beijing ¥4,500 (USD $620), Shanghai ¥4,800 (USD $660), Guangzhou ¥3,200 (USD $440). On-campus dormitories cost ¥800–¥1,500/month.

Career Outcomes and Global Recognition

Graduates from Chinese medical programs must pass the Medical Licensing Examination in their home country to practice. China’s MBBS degrees are recognized by the WHO, ECFMG (USA), GMC (UK), and Medical Council of India. In 2024, 76.4% of Chinese MBBS graduates who took the USMLE Step 1 passed on their first attempt — comparable to the 78% pass rate for US medical graduates. For research graduates, 62% of Chinese PhD holders in life sciences secured postdoctoral positions within 6 months of graduation, with top destinations including the US (38%), Germany (15%), and Singapore (12%). The Chinese government’s “Double First-Class” initiative has allocated ¥500 billion (USD $69 billion) since 2017 to boost 42 top universities, directly benefiting life sciences departments with new equipment, faculty recruitment, and international collaboration programs.

FAQ

Q1: Is a Chinese MBBS degree recognized in the United States?

Yes, the Educational Commission for Foreign Medical Graduates (ECFMG) recognizes MBBS degrees from 45+ Chinese universities listed in the World Directory of Medical Schools. Graduates must pass USMLE Step 1, Step 2 CK, and Step 2 CS to obtain ECFMG certification. In 2024, 1,240 Chinese MBBS graduates took the USMLE, with a first-time pass rate of 76.4%.

Q2: What are the language requirements for English-taught medical programs in China?

Most English-taught MBBS programs require IELTS 6.0 (no band below 5.5) or TOEFL iBT 80. Some top universities like Peking University require IELTS 6.5 or TOEFL 90. HSK (Chinese proficiency) is not required for English-taught programs, but HSK 4 is recommended for clinical rotations where patients speak Chinese.

Q3: How much does it cost to study medicine in China as an international student?

Tuition for MBBS programs ranges from ¥30,000 to ¥80,000 per year (USD $4,150–$11,060). Living costs add ¥2,500–¥6,000 per month (USD $345–$830). Total annual cost: ¥60,000–¥150,000 (USD $8,300–$20,730). CSC scholarships cover all costs; 12.4% of life sciences applicants received the scholarship in 2024.

References

  • Quacquarelli Symonds. 2025. QS World University Rankings by Subject: Life Sciences & Medicine.
  • Ministry of Education of the People’s Republic of China. 2024. Statistical Report on International Students in China.
  • China Scholarship Council. 2024. Annual Report on CSC Scholarship Awards.
  • Scimago Journal Rank. 2025. Country Rankings: Life Sciences Citation Metrics.
  • Unilink Education Database. 2025. Chinese University Admissions and Recognition Data.